Globus Medical Company Insiders

GMED Stock  USD 53.06  1.44  2.79%   
Globus Medical employs about 5 K people. The company is managed by 24 executives with a total tenure of roughly 126 years, averaging almost 5.0 years of service per executive, having 208.33 employees per reported executive. Evaluation of Globus Medical's management performance can provide insight into the firm performance.
David Paul  Chairman
Co-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance Committee
Eric Schwartz  President
Senior Vice President General Counsel
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Globus Medical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Globus Medical's future performance. Based on our forecasts, it is anticipated that Globus will maintain a workforce of about 5000 employees by April 2024.
 
Yuan Drop
 
Covid

Globus Medical's latest congressional trading

Congressional trading in companies like Globus Medical, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Globus Medical by those in governmental positions are based on the same information available to the general public.
2023-04-03Representative Josh GottheimerAcquired Under $15KVerify
2023-03-06Representative Daniel GoldmanDisposed $15K to $50KVerify
2020-06-01Representative Gilbert CisnerosDisposed Under $15KVerify
2015-02-13Senator Thom TillisAcquired Under $15KVerify

Globus Medical Management Team Effectiveness

The company has return on total asset (ROA) of 0.0477 % which means that it generated a profit of $0.0477 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0421 %, meaning that it created $0.0421 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities.

Globus Medical Workforce Comparison

Globus Medical is rated # 4 in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 140,593. Globus Medical holds roughly 5,000 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.

Globus Medical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Globus Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2023-12-01
4.0
4
1
 191,100 
 342,200 
2023-06-01
0.8
4
5
 43,450 
 86,900 
2023-03-01
2.5
15
6
 382,467 
 76,634 
2022-12-01
0.5
1
2
 7,500 
 15,000 
2022-06-01
1.0
2
2
 62,500 
 34,000 
2022-03-01
2.2
11
5
 425,000 
 28,360 
2021-09-01
0.4375
7
16
 104,166 
 210,332 
2021-06-01
0.6667
10
15
 323,022 
 646,044 
2021-03-01
4.3333
13
3
 515,768 
 46,152 
2020-12-01
0.6154
8
13
 70,220 
 331,295 
2020-09-01
0.6471
11
17
 696,305 
 1,060,000 
2020-06-01
0.8
4
5
 109,776 
 218,152 
2019-12-01
0.2857
2
7
 28,076 
 63,536 
2019-09-01
0.5
2
4
 90,000 
 103,000 
2019-06-01
1.0
1
1
 25,000 
 0.00 
2019-03-01
0.7097
22
31
 816,582 
 622,316 
2018-09-01
0.5
4
8
 1,151,812 
 2,011,818 
2018-06-01
0.65
26
40
 793,383 
 1,545,124 
2018-03-01
2.4286
17
7
 741,500 
 172,000 
2017-12-01
0.5
5
10
 73,459 
 175,996 
2017-09-01
1.0
1
1
 300,000 
 15,000 
2017-06-01
0.5
1
2
 16,153 
 32,306 
2017-03-01
6.0
12
2
 627,500 
 115,000 
2016-09-01
0.5
2
4
 107,692 
 215,384 
2016-03-01
2.5
15
6
 585,600 
 60,645 
2015-09-01
1.5
3
2
 215,000 
 20,000 
2015-06-01
0.25
1
4
 3,076 
 206,152 
2015-03-01
1.25
10
8
 532,500 
 2,115,663 
2014-06-01
0.8
4
5
 6,068,500 
 6,098,500 
2014-03-01
1.0625
17
16
 1,323,829 
 2,589,471 
2013-09-01
0.1538
2
13
 102,478 
 21,814,035 
2013-06-01
0.5556
5
9
 2,884,530 
 3,114,530 
2013-03-01
3.3333
10
3
 196,000 
 71,103 
2012-12-01
1.0
1
1
 435,350 
 870,700 
2012-09-01
0.7826
36
46
 42,672,634 
 91,725,660 

Globus Medical Notable Stakeholders

A Globus Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Globus Medical often face trade-offs trying to please all of them. Globus Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Globus Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David PaulCo-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance CommitteeProfile
Eric SchwartzSenior Vice President General CounselProfile
Andrew MurphyGroup President Commercial OperationsProfile
Anthony WilliamsSenior Vice President General CounselProfile
Brett MurphyGroup President of Commercial OperationsProfile
Keith PfeilChief Financial Officer, Senior Vice PresidentProfile
David DemskiGroup President of Emerging Technologies, Director and Member of Nominating and Corporate Governance CommitteeProfile
Daniel ScavillaExecutive Vice President, Chief Commercial Officer and President - TraumaProfile
Steve ZarrilliIndependent DirectorProfile
Ann RhoadsIndependent DirectorProfile
Robert LiptakIndependent DirectorProfile
James TobinIndependent DirectorProfile
Kurt WheelerIndependent DirectorProfile
Daniel LemaitreIndependent DirectorProfile
David DavidarCo-Founder, Sr. VP of Operations and DirectorProfile
Kelly EsqGeneral VPProfile
Mike ReederEx OfficerProfile
Robert DouglasIndependent DirectorProfile
Steven PayneVP ControllerProfile
Kelly HullerSenior Vice President General Counsel, Corporate SecretaryProfile
Stephen ZarrilliIndependent DirectorProfile
Brian KearnsSenior RelationsProfile
Richard HolifieldEx OfficerProfile
John DowlingEx OfficerProfile

About Globus Medical Management Performance

The success or failure of an entity such as Globus Medical often depends on how effective the management is. Globus Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Globus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Globus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people.
The data published in Globus Medical's official financial statements usually reflect Globus Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Globus Medical. For example, before you start analyzing numbers published by Globus accountants, it's critical to develop an understanding of what Globus Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Globus Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Globus Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Globus Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Globus Medical. Please utilize our Beneish M Score to check the likelihood of Globus Medical's management manipulating its earnings.

Globus Medical Workforce Analysis

Traditionally, organizations such as Globus Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Globus Medical within its industry.

Globus Medical Manpower Efficiency

Return on Globus Medical Manpower

Revenue Per Employee313.7K
Revenue Per Executive65.4M
Net Income Per Employee24.6K
Net Income Per Executive5.1M
Working Capital Per Employee304.6K
Working Capital Per Executive63.5M
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.